Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Breast Cancer Research : BCR
|
November 25, 2011
A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies
Elena Muraro, Debora Martorelli, Elisa Turchet, et al.
Critical Reviews in Oncology/Hematology
|
May 15, 2022
Tissue and circulating PD-L2: moving from health and immune-mediated diseases to head and neck oncology
Elena Muraro, Rebecca Romanò, Giuseppe Fanetti, et al.
BMC Cancer
|
December 17, 2014
Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients
Gianmaria Miolo, Elena Muraro, Debora Martorelli, et al.
Frontiers in Immunology
|
July 11, 2025
The influence of <i>H. pylori</i> infection in HER2-positive gastric cancer cell lines: insights from Wnt/β-catenin pathway
Valli De Re, Mariateresa Casarotto, Giulia Brisotto, et al.
Frontiers in Immunology
|
April 16, 2025
Radical hemithorax radiotherapy induces an increase in circulating PD-1<sup>+</sup> T lymphocytes and in the soluble levels of PD-L1 in malignant pleural mesothelioma patients: a possible synergy with PD-1/PD-L1 targeting treatment?
Alberto Revelant, Francesca Gessoni, Marcella Montico, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2012
IGKV3 proteins as candidate "off-the-shelf" vaccines for kappa-light chain-restricted B-cell non-Hodgkin lymphomas
Debora Martorelli, Massimo Guidoboni, Valli De Re, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 1, 2020
Radical Hemithoracic Radiotherapy Versus Palliative Radiotherapy in Non-metastatic Malignant Pleural Mesothelioma: Results from a Phase 3 Randomized Clinical Trial
Marco Trovo, Alberto Relevant, Jerry Polesel, et al.
Frontiers in Immunology
|
March 21, 2024
Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors
Elena Muraro, Barbara Montico, Benedict Lum, et al.
Viruses
|
June 28, 2023
Integration of Cellular and Humoral Immune Responses as an Immunomonitoring Tool for SARS-CoV-2 Vaccination in Healthy and Fragile Subjects
Giulia Brisotto, Marcella Montico, Matteo Turetta, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 19, 2015
Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis
Riccardo Dolcetti, Cinzia Giagulli, Wangxiao He, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Breast Cancer Research : BCR
|
November 25, 2011
A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies
Elena Muraro, Debora Martorelli, Elisa Turchet, et al.
Critical Reviews in Oncology/Hematology
|
May 15, 2022
Tissue and circulating PD-L2: moving from health and immune-mediated diseases to head and neck oncology
Elena Muraro, Rebecca Romanò, Giuseppe Fanetti, et al.
BMC Cancer
|
December 17, 2014
Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients
Gianmaria Miolo, Elena Muraro, Debora Martorelli, et al.
Frontiers in Immunology
|
July 11, 2025
The influence of <i>H. pylori</i> infection in HER2-positive gastric cancer cell lines: insights from Wnt/β-catenin pathway
Valli De Re, Mariateresa Casarotto, Giulia Brisotto, et al.
Frontiers in Immunology
|
April 16, 2025
Radical hemithorax radiotherapy induces an increase in circulating PD-1<sup>+</sup> T lymphocytes and in the soluble levels of PD-L1 in malignant pleural mesothelioma patients: a possible synergy with PD-1/PD-L1 targeting treatment?
Alberto Revelant, Francesca Gessoni, Marcella Montico, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2012
IGKV3 proteins as candidate "off-the-shelf" vaccines for kappa-light chain-restricted B-cell non-Hodgkin lymphomas
Debora Martorelli, Massimo Guidoboni, Valli De Re, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 1, 2020
Radical Hemithoracic Radiotherapy Versus Palliative Radiotherapy in Non-metastatic Malignant Pleural Mesothelioma: Results from a Phase 3 Randomized Clinical Trial
Marco Trovo, Alberto Relevant, Jerry Polesel, et al.
Frontiers in Immunology
|
March 21, 2024
Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors
Elena Muraro, Barbara Montico, Benedict Lum, et al.
Viruses
|
June 28, 2023
Integration of Cellular and Humoral Immune Responses as an Immunomonitoring Tool for SARS-CoV-2 Vaccination in Healthy and Fragile Subjects
Giulia Brisotto, Marcella Montico, Matteo Turetta, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 19, 2015
Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis
Riccardo Dolcetti, Cinzia Giagulli, Wangxiao He, et al.
Page
of 5